161 institutions reported holding $200.5M of KEROS THERAPEUTICS INC (KROS) in SEC 13F filings for 2026-06-30. Largest institutional holders: BlackRock, Inc. ($29.9M), VANGUARD GROUP INC ($17.4M), Nantahala Capital Management, LLC ($15.1M), AQR CAPITAL MANAGEMENT LLC ($10.4M), ORBIMED ADVISORS LLC ($8.1M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30